Synthesis of novel copper-labeled agents for PET imaging as an alternative to technetium radiopharmaceuticals
| Project/Area Number |
23591829
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Japan Atomic Energy Agency |
|---|
Principal Investigator |
SUGO Yumi 独立行政法人日本原子力研究開発機構, 原子力科学研究部門 量子ビーム応用研究センター, 研究副主幹 (90354836)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
WATANABE Shigeki 独立行政法人日本原子力研究開発機構, 原子力科学研究部門量子ビーム応用研究センター, 研究員 (10450305)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | 放射性同位元素 / ポジトロン / Cu-64 / ペプチド / 分子プローブ / 環状ペプチド |
|---|
| Research Abstract |
Technetium-99m (Tc-99m) is most commonly used as diagnostic radiopharmaceuticals. Tc-99m is generated by decay of molybdenum-99 (Mo-99), of which supply depends fully on the import from foreign countries. Recently, the supply shortage is the serious problem in the hospital.
Copper-64 (Cu-64) is a useful radionuclide in nuclear medicine, and can be produced by the cyclotron using (p,n) nuclear reaction from nickel-64 (Ni-64). In this study, we designed and synthesized some novel Cu-64 labeled agents for positron emission tomography (PET) imaging as an alternative to the Tc-99m radiopharmaceuticals.
|
Report
(4 results)
Research Products
(6 results)
